Alisha Clemons, APRN
Family · Lexington, KYNPI 1205375474
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Gilead accounts for 96.8% of it on its own, with 7 other manufacturers making up the rest. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $414.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$53K
- AbbVie$1K
- Paratek Pharmaceuticals, Inc.$244
- AstraZeneca$95
- Acadia Pharmaceuticals Inc$78
- Johnson & Johnson$53
- plus $65 from 2 others
What the payments were for
- Consulting fees$5,76011%
- Speaking & faculty fees$29,47554%
- Travel & lodging$14,38626%
- Food & beverage$5,0869%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 111 | $52,933 |
| AbbVie | 13 | $1,239 |
| Paratek Pharmaceuticals, Inc. | 3 | $244 |
| AstraZeneca | 1 | $95 |
| Acadia Pharmaceuticals Inc | 1 | $78 |
| Johnson & Johnson | 1 | $53 |
| Novo Nordisk | 1 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,707 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArikayceAmikacin Liposomal/Neb.Accessr | 19 | $247,261 |
| Posaconazole | 11 | $8,708 |
| Cefadroxil | 60 | $3,868 |
| Fosfomycin Tromethamine | 21 | $3,186 |
| Ethambutol Hcl | 43 | $2,747 |
| Rifampin | 40 | $2,243 |
| Doxycycline Monohydrate | 31 | $864 |
| Azithromycin | 41 | $732 |
| Fluconazole | 20 | $667 |
| Cephalexin | 30 | $626 |
| Levofloxacin | 21 | $435 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $296 |
| Doxycycline Hyclate | 22 | $213 |
Paid to pharmacies, not to this prescriber.
Other family in Lexington
- Timothy SmallwoodLexington$27K
- Lauren MaupinLexington$18K
- Emily MesserliLexington$13K
- Rhiannon BlackLexington$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.